Socioeconomic disparities in access to and outcomes of liver transplantation (LT) for hepatocellular carcinoma (HCC).

J Jongwoo Kim J Junho Song (2Penn State College of Medicine, Hershey, United States) W Wonjong Yang (Department of Medicine, Penn State College of Medicine, Hershey, PA) D Donghoon Shin (Department of Materials Science and Engineering) A Amy Choi (Penn State College of Medicine, Hershey, PA) S Seoin Kim (Metrowest Medical Center, Framingham, MA) M Myeong Hwak Choe (Department of Medicine, Penn State College of Medicine, Hershey, PA) H Hyoung Hwan Moon (Department of Surgery, College of Medicine at Kosin University, Busan, South Korea)

Abstract

e16337 Background: HCC is a leading indication for liver transplantation (LT) and a major contributor to cancer-related mortality worldwide. Access to LT is often shaped by social determinants of health, including insurance status, employment, and geographic region, which can impact waitlist duration and post-transplant survival. Methods: We retrospectively analyzed 20,492 adult patients with HCC listed for LT in the United Network for Organ Sharing (UNOS) database. Socioeconomic variables assessed at registration included highest education level, employment status, and primary payer type (public vs. private insurance). We used multivariable logistic regression, adjusted for clinical covariates, to examine associations between these factors and (1) waitlist duration and (2) post-transplant survival. Results: Patients with public insurance had longer median wait times (7.9 vs. 7.2 months, p < 0.01) and shorter post-transplant survival (37.3 vs. 44.9 months, p < 0.01) compared with those with private insurance. Male sex was independently associated with worse survival (HR 1.15, 95% CI 1.06–1.25, p < 0.01). Compared with White patients, African American patients had an increased risk of mortality (HR 1.19, 95% CI 1.07–1.33, p < 0.01), while Hispanic (HR 0.90, 95% CI 0.82–0.99, p = 0.03) and Asian (HR 0.69, 95% CI 0.59–0.81, p < 0.01) patients exhibited lower risks. Employment was protective factor of survival(HR 0.73, 95% CI 0.68–0.79, p < 0.01). Education level was not significantly associated with survival. Regional differences in median wait times were significant (p < 0.01), ranging from 8.9 months in the northeast region to 6.8 months in the south region. In patients undergoing two or more LTs, there was no significant difference in survival by sex (p = 0.59). Among males, employment rates decreased after the first LT (34.0% vs. 19.8%; p < 0.001), while among females, employment rates increased (22.0% vs. 85.1%; p < 0.001). Conclusions: Socioeconomic factors—particularly insurance status, employment, race/ethnicity, and region—continue to drive disparities in both access and survival outcome to LT for HCC. Targeted approaches, such as patient navigation services, expanded financial support, and systemic policy reforms, are critical to closing these gaps and improving patient outcomes.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (8)

J

Jongwoo Kim

J

Junho Song

2Penn State College of Medicine, Hershey, United States

W

Wonjong Yang

Department of Medicine, Penn State College of Medicine, Hershey, PA

D

Donghoon Shin

Department of Materials Science and Engineering

A

Amy Choi

Penn State College of Medicine, Hershey, PA

S

Seoin Kim

Metrowest Medical Center, Framingham, MA

M

Myeong Hwak Choe

Department of Medicine, Penn State College of Medicine, Hershey, PA

H

Hyoung Hwan Moon

Department of Surgery, College of Medicine at Kosin University, Busan, South Korea